IP Library Assignment 057785/0054
Patent Assignment
Reel/Frame 057785/0054

Security Interest

Recorded: 2021-10-04 Pages: 27
Assignor
ENSYSCE BIOSCIENCES, INC.
Executed: 2021-09-24
Assignee
3I, LP
140 BROADWAY, 38TH FLOOR, NEW YORK, NEW YORK, 10005
Covered Properties (25)
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Application: 16/656,409 →
Publication: US 2020/0253900
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Application: 15/042,906 →
Publication: US 2016/0235694
Modified Release Compositions of Nafamostat and Methods of Using Same
Application: 63/158,654 →
Compositions Comprising Enzyme-Cleavable Prodrugs and Controlled Release Nafamostat and Methods of Use Thereof
Application: 63/158,663 →
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Application: 17/436,041 →
Publication: US 2022/0175699
Single-Walled Carbon Nanotube/Sirna Complexes and Methods Related Thereto
Patent: 8,772,258 →
Application: 13/175,314 →
Publication: US 2012/0003278
Prodrugs of Active Agents
Patent: 8,163,701 →
Application: 11/508,042 →
Publication: US 2007/0123468
Controlled Release of Phenolic Opioids
Patent: 8,217,005 →
Application: 12/302,764 →
Publication: US 2010/0035826
Controlled Release of Phenolic Opioids
Patent: 8,921,418 →
Application: 13/486,613 →
Publication: US 2012/0270894
Pro-Drugs for Controlled Release of Biologically Active Compounds
Patent: 9,023,860 →
Application: 12/324,383 →
Publication: US 2009/0137618
Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids
Patent: 8,802,681 →
Application: 13/121,335 →
Publication: US 2011/0281886
Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids
Patent: 9,534,014 →
Application: 14/320,351 →
Publication: US 2015/0031635
Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
Patent: 9,493,477 →
Application: 13/393,470 →
Publication: US 2012/0230916
Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
Application: 15/285,818 →
Publication: US 2017/0119754
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 8,569,228 →
Application: 13/346,062 →
Publication: US 2012/0178772
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 8,962,547 →
Application: 14/035,871 →
Publication: US 2014/0162935
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 9,499,581 →
Application: 14/593,855 →
Publication: US 2015/0197544
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 8,497,237 →
Application: 13/346,281 →
Publication: US 2012/0178773
Compositions Comprising Enzyme-Cleavable Phenol-Modified Tapentadol Prodrug
Patent: 9,238,020 →
Application: 13/634,530 →
Publication: US 2013/0090379
Compositions Comprising Enzyme-Cleavable Opioid Prodrugs and Inhibitors Thereof
Patent: 9,040,032 →
Application: 13/686,725 →
Publication: US 2013/0210701
Compositions Comprising Enzyme-Cleavable Opioid Prodrugs and Inhibitors Thereof
Patent: 9,585,963 →
Application: 14/692,526 →
Publication: US 2015/0297736
Opioid Prodrugs with Heterocyclic Linkers
Patent: 8,685,916 →
Application: 13/415,790 →
Publication: US 2012/0295834
Opioid Prodrugs with Heterocyclic Linkers
Patent: 9,095,627 →
Application: 14/166,719 →
Publication: US 2014/0206597
Active Agent Prodrugs with Heterocyclic Linkers
Patent: 9,139,612 →
Application: 14/000,594 →
Publication: US 2014/0121152
Methods for Treating Viral Infections with Nafamostat
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 16, 2007
From: JENKINS, THOMAS E.
To: PHARMACOFORE, INC.
Reel/Frame 018897/0471 →
Assignment of Assignor's Interest Feb 5, 2009
From: JENKINS, THOMAS E.
To: PHARMACOFORE, INC.
Reel/Frame 022213/0548 →
Assignment of Assignor's Interest Jul 24, 2009
From: JENKINS, THOMAS E.; KOLESNIKOV, ALEKSANDR
To: PHARMACOFORE, INC.
Reel/Frame 023004/0505 →
Assignment of Assignor's Interest Apr 20, 2011
From: JENKINS, THOMAS E.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 026156/0210 →
Assignment of Assignor's Interest Aug 1, 2011
From: KIRKPATRICK, D. LYNN; WEISS, MICHELLE K.
To: ENSYSCE BIOSCIENCES, INC.
Reel/Frame 026681/0252 →
Change of Name Mar 2, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 027800/0461 →
Assignment of Assignor's Interest Mar 2, 2012
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 027799/0899 →
Assignment of Assignor's Interest Mar 15, 2012
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 027871/0916 →
Change of Name Mar 20, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 027892/0697 →
Change of Name May 9, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 028185/0192 →
Assignment of Assignor's Interest May 10, 2012
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 028191/0172 →
Assignment of Assignor's Interest Sep 7, 2012
From: JENKINS, THOMAS E.; KOLESNIKOV, ALEKSANDR
To: PHARMACOFORE, INC.
Reel/Frame 028920/0757 →
Change of Name Sep 7, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 028923/0329 →
Change of Name May 6, 2013
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 030359/0504 →
Assignment of Assignor's Interest May 6, 2013
From: JENKINS, THOMAS E.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 030358/0340 →
Assignment of Assignor's Interest Jun 11, 2014
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 033073/0457 →
Change of Name Oct 15, 2014
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 034009/0199 →
Assignment of Assignor's Interest Oct 15, 2014
From: JENKINS, THOMAS E.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 033957/0558 →
Assignment of Assignor's Interest Mar 30, 2015
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 035291/0665 →
Assignment of Assignor's Interest Jan 27, 2017
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 041112/0182 →
Change of Name Jan 27, 2017
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 041541/0166 →
Change of Name Mar 6, 2017
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 041895/0557 →
Assignment of Assignor's Interest Mar 6, 2017
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 041478/0046 →
Release of Security Interest Sep 24, 2018
From: MMV FINANCE INC.
To: NETBASE SOLUTIONS, INC.
Reel/Frame 047140/0588 →
Assignment of Assignor's Interest Mar 12, 2021
From: KIRKPATRICK, LYNN
To: ENSYSCE BIOSCIENCES INC.
Reel/Frame 055580/0919 →